| |
| |
|
| Insider
Information: |
Hansen Gwenn |
| Relationship: |
Chief Scientific Officer |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,601 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,601 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nurix Therapeutics, Inc. |
NRIX |
Chief Scientific Officer |
2024-04-30 |
39,601 |
2020-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-04-30 |
4 |
S |
$12.04 |
$24,169 |
D/D |
(2,007) |
39,601 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,206 |
41,608 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-01-30 |
4 |
S |
$7.99 |
$18,649 |
D/D |
(2,334) |
36,402 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,207 |
38,736 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-10-31 |
4 |
S |
$5.20 |
$8,487 |
D/D |
(1,633) |
33,529 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,207 |
35,162 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-07-31 |
4 |
S |
$9.65 |
$18,189 |
D/D |
(1,884) |
29,955 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,207 |
31,839 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-05-01 |
4 |
S |
$9.88 |
$11,219 |
D/D |
(1,136) |
26,632 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,206 |
27,768 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-01-30 |
4 |
S |
$11.78 |
$16,633 |
D/D |
(1,412) |
23,009 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,207 |
24,421 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-31 |
4 |
S |
$12.88 |
$15,006 |
D/D |
(1,165) |
21,214 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,207 |
22,379 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-08-01 |
4 |
S |
$15.67 |
$18,585 |
D/D |
(1,186) |
19,172 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,207 |
20,358 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-05-02 |
4 |
S |
$11.75 |
$12,902 |
D/D |
(1,098) |
17,151 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,206 |
18,249 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-01-03 |
4 |
OE |
$7.26 |
$16,570 |
D/D |
1,828 |
16,025 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-01-03 |
4 |
AS |
$28.96 |
$52,939 |
D/D |
(1,828) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-01 |
4 |
AS |
$29.13 |
$11,652 |
D/D |
(400) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,597 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-01 |
4 |
AS |
$33.24 |
$13,296 |
D/D |
(400) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,597 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-27 |
4 |
AS |
$35.00 |
$14,000 |
D/D |
(400) |
14,197 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
